#orthopedic product company

[geniusorthoindustries]

At Genius Ortho Industries, we're proud to be a top supplier of superior orthopaedic implants that meet the changing demands of the healthcare sector. We provide an extensive selection of orthopedic implants and tools that are intended to improve surgical results and patient satisfaction. We are dedicated to innovation, accuracy, and patient-centered solutions.

[salveolifecare]

Orthopedic Company in India

At Orthopedic Company, specialize in providing top-quality medical devices and personalized care to enhance mobility, reduce pain, and improve the quality of life for patients. Leading the Orthopedic Company in India, our company excels in providing advanced solutions for bone and joint health. Our advanced implants, surgical instruments, and rehabilitation devices are crafted with precision and care. Committed to enhancing patient outcomes. Salveo Lifecare prioritizes innovation, quality, and affordability, ensuring that everyone can access world-class orthopedic care.

[siorasurgical-post]

What Are Orthopedic Tibia Plates? A Quick Guide

Orthopedic tibia plates are medical devices used by surgeons to stabilize and promote healing in fractured tibias. These plates are typically made of biocompatible titanium, a strong yet lightweight metal that minimizes the risk of rejection by the body. They come in various shapes and sizes to accommodate different fracture locations and types.

[siiorasurgicle]

Orthopedic Trauma Implants in Indonesia | Siiora

Joint replacements have become common in the last 5–10 years. Thanks to the advancing technology and improvement in the quality of Orthopedic Trauma implants. The decision to joint replacement is taken when there is no other option left to improve painful symptoms.

[zephonlifesciences]

Orthopedic PCD Franchise in India | Zephon Lifesciences

Discover the lucrative opportunities in the orthopedic PCD franchise business in India with Zephon Lifesciences. In this informative video, we explore the benefits and advantages of partnering with Zephon Lifesciences for the orthopedic PCD franchise in India. From a wide range of high quality orthopedic products to marketing support and monopoly rights, Zephon Lifesciences offers a strong platform for growth and success. Learn how you can become a part of this booming industry and take your entrepreneurial journey to new heights. #OrthopedicPCDFranchiseinIndia #OrthopedicPCDFranchise #OrthopedicFranchiseinIndia #OrthopedicFranchise

[transmutationisms]

can u elaborate on posture being a lie

As Beth Linker explains in her book “Slouch: Posture Panic in Modern America” (Princeton), a long history of anxiety about the proximity between human and bestial nature has played out in this area of social science. Linker, a historian of medicine at the University of Pennsylvania, argues that at the onset of the twentieth century the United States became gripped by what she characterizes as a poor-posture epidemic: a widespread social contagion of slumping that could, it was feared, have deleterious effects not just upon individual health but also upon the body politic. Sitting up straight would help remedy all kinds of failings, physical and moral [...] she sees the “past and present worries concerning posture as part of an enduring concern about so-called ‘diseases of civilization’ ”—grounded in a mythology of human ancestry that posits the hunter-gatherer as an ideal from which we have fallen.

[...]

In America at the turn of the twentieth century, anxieties about posture inevitably collided with anxieties not just about class but also about race. Stooping was associated with poverty and with manual, industrialized labor—the conditions of working-class immigrants from European countries who, in their physical debasement, were positioned well below the white Anglo-Saxon Protestant establishment. Linker argues that, in this environment, “posture served as a marker of social status similar to skin color.” At the same time, populations that had been colonized and enslaved were held up as posture paradigms for the élite to emulate: the American Posture League rewarded successful students with congratulatory pins that featured an image of an extremely upright Lenape man. The head-carrying customs associated with African women were also adopted as training exercises for white girls of privilege, although Linker notes that Bancroft and her peers recommended that young ladies learn to balance not baskets and basins, which signified functionality, but piles of flat, slippery books, markers of their own access to leisure and education. For Black Americans, posture was even more fraught: despite the admiration granted to the posture of African women bearing loads atop their heads, community leaders like Dr. Algernon Jackson, who helped establish the National Negro Health Movement, criticized those Black youth who “too often slump along, stoop-shouldered and walk with a careless, lazy sort of dragging gait.” If slouching among privileged white Americans could indicate an enviable carelessness, it was seen as proof of indolence when adopted by the disadvantaged.

This being America, posture panic was swiftly commercialized, with a range of products marketed to appeal to the eighty per cent of the population whose carriage had been deemed inadequate by posture surveys. The footwear industry drafted orthopedic surgeons to consult on the design of shoes that would lessen foot and back pain without the stigma of corrective footwear: one brand, Trupedic, advertised itself as “a real anatomical shoe without the freak-show look.” The indefatigable Jessie Bancroft trained her sights on children’s clothing, endorsing a company that created a “Right-Posture” jacket, whose trim cut across the upper shoulders gave its schoolboy wearer little choice but to throw his shoulders back like Jordan Baker. Bancroft’s American Posture League endorsed girdles and corsets for women; similar garments were also adopted by men, who, by the early nineteen-fifties, were purchasing abdominal “bracers” by the millions.

It was in this era that what eventually proved to be the most contentious form of posture policing reached its height, when students entering college were required to submit to mandatory posture examinations, including the taking of nude or semi-nude photographs. For decades, incoming students had been evaluated for conditions such as scoliosis by means of a medical exam, which came to incorporate photography to create a visual record. Linker writes that for many male students, particularly those who had military training, undressing for the camera was no biggie. For female students, it was often a more disquieting undertaking. Sylvia Plath, who endured it in 1950, drew upon the experience in “The Bell Jar,” whose protagonist, Esther Greenwood, discovers that undressing for her boyfriend is as uncomfortably exposing as “knowing . . . that a picture of you stark naked, both full view and side view, is going into the college gym files.” The practice of taking posture photographs was gradually abandoned by colleges, thanks in part to the rise of the women’s movement, which gave coeds a new language with which to express their discomfort. It might have been largely forgotten were it not for a 1995 article in the Times Magazine, which raised the alarming possibility that there still existed stashes of nude photographs of famous former students of the Ivy League and the Seven Sisters, such as George H. W. Bush, Bob Woodward, Meryl Streep, and Hillary Clinton. Many of the photographs in question were taken and held not by the institutions themselves but by the mid-century psychologist William Herbert Sheldon. Sheldon was best known for his later discredited theories of somatotypes, whereby he attributed personality characteristics to individuals based on whether their build was ectomorphic, endomorphic, or mesomorphic.

[...]

Today, the descendants of Jessie Bancroft are figures like Esther Gokhale, a Bay Area acupuncturist and the creator of the Gokhale Method, who teaches “primal posture” courses to tech executives and whose recommendations are consonant with other fitness trends, such as barefoot running and “paleo” eating, that romanticize an ancestral past as a remedy for the ills of the present. The compulsory mass surveillance that ended when universities ceased the practice of posture photography has been replaced by voluntary individual surveillance, with the likes of Rafi the giraffe and the Nekoze cat monitoring a user’s vulnerability to “tech neck,” a newly named complaint brought on by excessive use of the kind of devices profitably developed by those paleo-eating, barefoot-running, yoga-practicing executives. Meanwhile, Linker reports, paleoanthropologists quietly working in places other than TikTok have begun to revise the popular idea that our ancient ancestors did not get aches and pains in their backs. Analysis of fossilized spines has revealed degenerative changes suggesting that “the first upright hominids to roam the earth likely experienced back pain, or would have been predisposed to such a condition if they had lived long enough.” Slouching, far from being a disease of civilization, then, seems to be something we’ve been prone to for as long as we have stood on our own two feet.

[songmingisthighs]

atinytwt is so stupid and toxic oh my god i just saw someone "shading" kq for jongho ???? like okay let me put down my points

a. we don't actually know how they decide to let or allow jongho to only receive injections and medication. jongho's condition was explained by an indonesian orthopedic surgeon who said that NORMALLY injection and medication COULD aid and alleviate the pain but considering jongho's occupation and activity (i.e. dancing), recurrence is expected and it needed a more permanent solution. also, jongho is a grown ass adult, let's not baby him too much (despite me wanna go goochie goochie goo and tuck him into bed with warm milk and cookies) and think that jongho is incapable of making a huge decision for his own health no matter the consequence

b. "kq put them in crazy schedules" it's literally the pitfalls of being idols my ghawd do you want them to not tour and expand their reach and just sit pretty with one comeback a year ??? sure, they could do that but they'll need money to get better production quality like you buying one album per comeback or one album per version is not enough to even cover the shoe budget, do you think those things are cheap ??? considering album sales are not pure as it's separated as distributor and company and from the company's cuts, it's further broken down and ateez will only get a sliver if any, they have to depend on miscelaneous schedules like radio, tv shows, joint concerts, festivals, etc. And no it's not unfair because there are calculations put in place and no matter what you do, the cuts will never be enough but at least from what we see, ateez is living rather well

c. compared to the big 4 (ion even wanna get into TS, cube, mld, mbk, etc. bc yuck) kq is a far better situation for ateez and xikers. like we haven't heard much from xikers, but we know that ateez praises kq. hongjoong even said that kq's ceo goes everywhere with them on tour (hj said this on the singapore concert) except for the show in manila bc he had a prior engagement. and dude, the gifts the ceo gave ateez and the fact that kq didn't put ateez on diets they don't want and how the staff interacts with ateez and ateez with the staff. idk, i've only been seeing green flags so far. ofc no one is perfect but again, compared to jyp who made momo eat only ice cubes to achieve her target weight so she can debut, or shoving all of seventeen in one tiny ass dorm that didn't seem like there were any blankets around during pre-debut, or putting the members on a leash and treating them like dogs like infinite, i actually love kq. I've liked kpop for over a decade now, since i was like in 5th grade and i've truly never seen a happier group than ateez.

is there a way to not read stupid ass posts on twt or x or wtv and just save pictures from there ??? really i have low tolerance in stupidity bc i have to deal with my own on a daily basis

[audible-smiles]

Most GP vets I know recommend glucosamine and chondroitin sulfate supplementation for dog at risk of osteoarthritis. They're both precursors to substances naturally found in cartilage, and the general claim is that supplementation reduces joint inflammation and protects cartilage from damage. Typically these are sold under the names Cosequin or Dasuquin. They're very popular with dog owners, and very commonly sold by both pet stores and vets.

I just went to a talk on osteoarthritis by an orthopedic specialist, and she claimed that these supplements were a waste of money, because they're not very bioavailable. The molecules are too large to make it through the GI system intact, and don't get to the joints where they'd be useful. So they're promising in vitro but aren't clinically useful.

So, rather than take her word for it, I looked it up. I found a 2017 literature review on the subject. Their conclusions are so frustrating that I want to quote directly from the article:

"Despite the trend towards more stringent criteria for veterinary nutraceutical products, the research community continues to conduct and publish novel, low-quality studies without consistent evaluation methods and varying products/doses...

These results are of questionable validity due to several trial shortcomings. First is the absence of therapeutic standardization. The sources of active ingredients, manufacturers of products, formulations, combinations of active ingredients, treatment doses, regimens, and durations of therapy differed significantly between trials. Second, multiple potential sources of bias were present in the trials, including the lack of a standardized follow-up timeframe, unexplained loss to follow-up, flawed study protocols, and incomplete data sets. Moreover, all of the clinical trials relied on subjective outcome measures to some extent, and the absence of standardized owner and veterinarian assessments increased the risk of bias in the reported results and diminished internal study validity.

The trials generally lacked peer review and were at risk of funding bias due to company sponsorship. Finally, there was an overall lack of generalizability of trial results. The trials were small in terms of the number of subjects used and subject baseline characteristics were not always disclosed...

Based on the available literature, the potential benefits of glucosamine and chondroitin use in osteoarthritic canines can neither be confirmed nor denied."

We are still so far behind human medicine in terms of evidence-based medicine...and human medicine is already worse than you'd hope. It's maddening. So in conclusion, I have no idea whether Cosequin/Dasuquin is helpful at all, and neither does anyone else.

[geniusorthoindustries]

Trust the knowledge and experience of Genius Ortho Industries when it comes to surgical instruments and orthopaedic implants. Medical professionals throughout India choose us because of our broad product offering, affordable prices, and dedication to quality. Visit: https://indianortho.com/

[siorasurgical-post]

Understanding Hip Arthroplasty - A Quick Guide

The hip joint is the unsung hero of our bodies. It bears a tremendous amount of weight and responsibility. It allows us to walk, run, climb stairs, and navigate the world with ease. But what happens when this crucial joint suffers damage? It leads to chronic pain and limited mobility. This is where hip arthroplasty, also known as hip replacement surgery, comes in. The surgery requires hip replacement trauma implants. In this blog, we will discuss Hip arthroplasty in detail.

[sioraindonesia]

How to Prevent Osteoporotic Fractures?

Osteoporotic fractures, characterized by weakened bones, are a severe health concern, particularly among the elderly population. Orthopedic implants may require to be placed in severe fractures. The good news is that there are effective strategies to prevent these fractures and maintain bone health throughout life. By adopting a proactive approach and making lifestyle changes, individuals can significantly reduce their risk of osteoporotic fractures.

[healthcare-domain]

Compression Therapy Market Regional Trends, Growth Projection and Global Industry Analysis Report

Increasing large target patient population and the rising incidence of sports injuries and accidents are the major factors driving the growth of this market. Moreover, strong focus of players in expanding their product offerings in compression therapy is anticipated to support the growth of the market. However, poor patient compliance for compression products is expected to restrain the growth of this market during the forecast period.

Globally, an increasing number of people are actively participating in sports and physical activities (as a result of the growing awareness about health and fitness). This trend has, in turn, increased the incidence of sports injuries and injuries related to other physical fitness activities. In the US alone, ~8.6 million sports injuries are registered annually (Source: US Department of Health and Human Services, data as of 2021).

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146548022

Patient non-compliance to compression products and non-adherence to treatment protocols are the common issues related to compression therapy. The non-compliance rate increases particularly in long-term treatments, where the primary aim is to prevent the occurrence of a specific condition (such as the occurrence/reoccurrence of ulcers). Since compression therapy is generally used as a preventive therapy in a majority of cases, the compliance rate of patients to the therapy decreases over time. Moreover, conditions such as pain, swelling, and skin irritation are associated with the regular use of compression garments.

Increasing sales of compression products through e-commerce websites and off-the-shelf channels across mature markets are expected to offer significant growth opportunities for the manufacturers of compression therapy products.

Compression bandages are the first line of treatment of venous diseases and are used to prevent their recurrence during compression therapy. The increasing prevalence of diabetes and the rising geriatric population prone to venous ulcers, foot ulcers, varicose veins, edema and growing availability of compression bandages in the market are  expected to support the growth of the compression bandages market during the forecast period.  

Rapid growth in the geriatric population, rising number of orthopedic and spinal surgeries, and the presence of various compression therapy product manufacturers in the region. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the rapid expansion of the target patient population in several Asia Pacific countries.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=146548022

Compression Therapy Market Dynamics:

Drivers:

Large target patient population

Growing incidence of sports injuries and accidents

Increasing number of orthopedic procedures

Greater product affordability and market availability

Clinical evidence favoring adoption of compression therapy for management of target conditions

Restraints:

Lack of universally accepted standards for compression products

Low patient compliance with compression garments

Opportunities:

Growth potential offered by emerging markets

Growing patient awareness regarding benefits of compression therapy

Increased sales of off-the-shelf and online products

Direct-to-consumer orthodontics

Challenges:

Significant adoption of alternative therapies for specific target indications

Increasing pricing pressure on market players

Key Market Players:

The major players operating in the global compression therapy market are DJO Global, Inc. (US), BSN medical (US), medi GmbH & Co. KG (Germany), Tactile Medical (US), SIGVARIS (Switzerland), Paul Hartmann AG (Germany), Sanyleg S.r.l. (Italy), 3M Company (US), ConvaTec Inc. (US), ArjoHuntleigh (Getinge Group, Sweden), and Julius Zorn GmbH (Germany)

[shubhampawrainfinium]

Viscosupplementation in Focus: The Latest Advances in Joint Lubrication

The global viscosupplementation market is on a growth trajectory, driven by increasing awareness of joint health and advancements in treatment options. According to the report, the market is projected to grow at a compound annual growth rate (CAGR) of nearly 7% over the forecast period of 2022-2028. With a revenue of over USD 3 billion in 2022, the market is expected to reach approximately USD 5 billion by 2028.

What is Viscosupplementation?

Viscosupplementation involves the injection of hyaluronic acid (HA) or other viscoelastic substances into the joint space to alleviate pain and improve joint function. This treatment is commonly used for managing osteoarthritis (OA) and other joint-related conditions. The injected material helps to lubricate the joint, reduce friction, and provide cushioning, leading to pain relief and improved mobility.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/887

Market Dynamics and Growth Drivers

Several factors are contributing to the growth of the global viscosupplementation market:

Rising Prevalence of Osteoarthritis: The increasing incidence of osteoarthritis, particularly among the aging population, is driving the demand for viscosupplementation treatments. OA is a leading cause of joint pain and disability, and viscosupplementation provides an effective option for managing symptoms.

Advancements in Technology: Technological advancements in viscosupplementation products, including the development of new formulations and delivery systems, are enhancing the effectiveness and safety of treatments. Innovations in hyaluronic acid formulations and injection techniques are contributing to market growth.

Growing Awareness and Acceptance: There is increasing awareness among patients and healthcare providers about the benefits of viscosupplementation for joint health. As more people become aware of this treatment option, the demand for viscosupplementation is expected to rise.

Increasing Number of Orthopedic Procedures: The rising number of orthopedic procedures, including joint injections and minimally invasive surgeries, is driving the demand for viscosupplementation products. Healthcare providers are increasingly incorporating viscosupplementation into treatment plans for managing joint conditions.

Supportive Reimbursement Policies: Favorable reimbursement policies and coverage for viscosupplementation treatments are encouraging patients to seek these therapies. Insurance coverage and reimbursement support contribute to the accessibility and affordability of viscosupplementation.

Regional Analysis

North America: North America is a leading market for viscosupplementation, driven by the high prevalence of osteoarthritis, advanced healthcare infrastructure, and strong demand for joint health solutions. The U.S. and Canada are key markets, with significant adoption of viscosupplementation treatments.

Europe: Europe is experiencing steady growth in the viscosupplementation market, supported by increasing awareness of joint health and advancements in treatment options. Countries such as Germany, France, and the U.K. are prominent markets, with growing adoption of viscosupplementation therapies.

Asia-Pacific: The Asia-Pacific region is witnessing rapid growth in the viscosupplementation market, driven by rising healthcare expenditures and increasing prevalence of joint disorders. Emerging economies in the region, such as China and India, are contributing to market expansion.

Latin America and Middle East & Africa: These regions are also experiencing growth in the viscosupplementation market, influenced by increasing healthcare infrastructure and rising awareness of joint health. Market expansion is supported by growing healthcare investments and improving access to treatments.

Competitive Landscape

The viscosupplementation market is competitive, with several key players and emerging companies offering a range of products. Notable players in the market include:

Allergan plc: A leading provider of viscosupplementation products, known for its Juvederm® range of hyaluronic acid-based injectables.

Medytox Inc.: Offers a range of viscosupplementation products, including hyaluronic acid-based solutions for joint health.

Revance Therapeutics, Inc.: Specializes in viscosupplementation treatments and innovative hyaluronic acid formulations.

Smith & Nephew plc: Provides viscosupplementation products for joint health and orthopedic applications.

Hylan Bio Inc.: Known for its hyaluronic acid-based viscosupplementation products for managing joint pain.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-viscosupplementation-market

Challenges and Opportunities

The viscosupplementation market faces challenges such as the high cost of treatment and the need for periodic injections, which may affect patient compliance. Additionally, there may be variability in the efficacy of viscosupplementation products and the potential for adverse effects.

However, there are significant opportunities for growth. Increasing adoption of minimally invasive procedures, advancements in product formulations, and supportive reimbursement policies present avenues for market expansion. Companies that focus on innovation, cost reduction, and improving patient outcomes are well-positioned to capitalize on the growing demand for viscosupplementation treatments.

Conclusion

The global viscosupplementation market is poised for substantial growth, driven by rising prevalence of osteoarthritis, technological advancements, and increasing awareness of joint health. With revenue expected to reach approximately USD 5 billion by 2028, the market presents significant opportunities for investment and innovation. As the demand for effective joint health solutions continues to rise, viscosupplementation will play a crucial role in enhancing quality of life for individuals with joint conditions.